This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (22)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Isabelle Hellier, MD; Didier Bessis, MD
Montpellier

Albert Sotto, MD, PhD
Nîmes, France

Geneviève Margueritte, MD
Montpellier

Jean-Jacques Guilhou, MD
Service de Dermatologie-Phlébologie Hôpital Saint Charles 300 rue Auguste Broussonnet 34295 Montpellier Cedex 5, France

Arch Dermatol. 1996;132(5):590-591.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Waltzer and Flowers¹ have identified a chemotherapy-induced bullous variant of acral erythema that is always associated with cytarabine, given alone or in combination with other agents. We report a case of bullous acral erythema occurring after the administration of high-dose methotrexate to an adolescent patient.

Report of a Case.

A 13-year-old girl was treated with methotrexate for chondroblastic osteogenic sarcoma of the left humerus at a dose of 12 g/m² (14 g per cycle). Each cycle was given at 1-week intervals. Within 24 hours following the seventh cycle, a symmetrical, edematous, painful, red, violaceous erythema developed on the balls of the feet and the fleshy part of the toes. A slight redness was noted on the palms of the hands. Over a 72-hour period, the plantar erythema became covered with large bullae, especially on the pressure points (Figure 1). Simultaneously, diffuse macular lesions, which were purpuric and necrotic . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?